Information
220 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
+82 31-622-5799
-
Overview
- Summary
- Sartorius Korea Biotech (유) is the Korean subsidiary of Sartorius, a global life science company with 150 years of tradition in Germany. The company provides cutting-edge equipment, consumables, and services across various industries including bio/pharmaceutical, food, chemical, semiconductor, universities, and government agencies. It primarily focuses on delivering integrated bioprocessing solutions such as bioreactors, cell culture media, and fluid management systems for R&D, quality assurance, and manufacturing of biopharmaceuticals. The company serves as a key partner in the safe, rapid, and economical development and production of biopharmaceuticals like therapeutic antibodies, biosimilars, and vaccines. It contributes to the growth of the domestic bio-industry and strengthens its position as a global bio-production hub.Sartorius Korea Biotech (유) is the Korean subsidiary of Sartorius, a global life science company with 150 years of tradition in Germany. The company provides cutting-edge equipment, consumables, and services across various industries including bio/pharmaceutical, food, chemical, semiconductor, universities, and government agencies. It primarily focuses on delivering integrated bioprocessing solutions such as bioreactors, cell culture media, and fluid management systems for R&D, quality assurance, and manufacturing of biopharmaceuticals. The company serves as a key partner in the safe, rapid, and economical development and production of biopharmaceuticals like therapeutic antibodies, biosimilars, and vaccines. It contributes to the growth of the domestic bio-industry and strengthens its position as a global bio-production hub.
- Key Products/Technologies
- Bioprocess Solutions (BPS): Bioreactors and fermenters, cell culture media and buffers, fluid management systems, purification and filtration systems, single-use systems (disposable bags, single-use bioreactors), and bioplant design and engineering services.Bioprocess Solutions (BPS): Bioreactors and fermenters, cell culture media and buffers, fluid management systems, purification and filtration systems, single-use systems (disposable bags, single-use bioreactors), and bioplant design and engineering services.
- Lab Products & Services (LPS): Laboratory balances, Lab Water systems, pipettes, Lab Filtration products, microbiology-related products, and analytical instruments supporting the entire biopharmaceutical development process.Lab Products & Services (LPS): Laboratory balances, Lab Water systems, pipettes, Lab Filtration products, microbiology-related products, and analytical instruments supporting the entire biopharmaceutical development process.
- Core Technologies: Key capabilities in high-value technologies such as Disposable Technology and sensor technology. Provision of cell bank manufacturing and cell line characterization testing services.Core Technologies: Key capabilities in high-value technologies such as Disposable Technology and sensor technology. Provision of cell bank manufacturing and cell line characterization testing services.
- mRNA and Cell & Gene Therapy Platforms: Equipment and solutions for mRNA production including Sartoflow®TFF Hydrosart®30-300KD, Sartopore ® 2 XLG, Pro Mixer & Biostat®, Sartorius Plasmid solutions, OctoPlus FF®, and CIMmultus® Monolith. Solutions for cell and gene therapy development (PBMC, CAR-T, TCR-T, CAR-Treg, TIL, NK, iNKT, CAR-NK, CAR-MΦ, BM-MSC, UC-MSC, AT-MSC, iPSCs, ESCs) such as Sartorius Cell Exploration and Characterization Solution, Sartorius Cell Optimization and Characterization Solution, Sartorius Cell Pilot Solution, Sartorius Cell Manufacturing Solution, Sartorius T-Cell Screening Solution, and Sartorius MSC Functional and Phenotypic Characterization Solution.mRNA and Cell & Gene Therapy Platforms: Equipment and solutions for mRNA production including Sartoflow®TFF Hydrosart®30-300KD, Sartopore ® 2 XLG, Pro Mixer & Biostat®, Sartorius Plasmid solutions, OctoPlus FF®, and CIMmultus® Monolith. Solutions for cell and gene therapy development (PBMC, CAR-T, TCR-T, CAR-Treg, TIL, NK, iNKT, CAR-NK, CAR-MΦ, BM-MSC, UC-MSC, AT-MSC, iPSCs, ESCs) such as Sartorius Cell Exploration and Characterization Solution, Sartorius Cell Optimization and Characterization Solution, Sartorius Cell Pilot Solution, Sartorius Cell Manufacturing Solution, Sartorius T-Cell Screening Solution, and Sartorius MSC Functional and Phenotypic Characterization Solution.
- Core Advantages
- Global Leader's Technology and Quality Standards: As the Korean subsidiary of Sartorius, a German global life science company with 150 years of scientific tradition, applying the parent company's accumulated global quality standards and cutting-edge technology to the domestic bio-industry.Global Leader's Technology and Quality Standards: As the Korean subsidiary of Sartorius, a German global life science company with 150 years of scientific tradition, applying the parent company's accumulated global quality standards and cutting-edge technology to the domestic bio-industry.
- Integrated Biopharmaceutical Process Solutions: Unique capability to provide integrated foundational technologies, equipment, consumables, and services covering the entire biopharmaceutical development and production lifecycle, from R&D, preclinical, fermentation, cell culture, purification, filtration, quality control, to manufacturing processes.Integrated Biopharmaceutical Process Solutions: Unique capability to provide integrated foundational technologies, equipment, consumables, and services covering the entire biopharmaceutical development and production lifecycle, from R&D, preclinical, fermentation, cell culture, purification, filtration, quality control, to manufacturing processes.
- First Domestic GMP Certification for Raw Material Manufacturing: The first company in Korea to obtain GMP (Good Manufacturing Practice) certification for biopharmaceutical raw material manufacturing facilities from the Ministry of Food and Drug Safety, ensuring the quality reliability of cell bank manufacturing and cell line characterization testing, and playing a leading role in localizing bio-materials, parts, and equipment.First Domestic GMP Certification for Raw Material Manufacturing: The first company in Korea to obtain GMP (Good Manufacturing Practice) certification for biopharmaceutical raw material manufacturing facilities from the Ministry of Food and Drug Safety, ensuring the quality reliability of cell bank manufacturing and cell line characterization testing, and playing a leading role in localizing bio-materials, parts, and equipment.
- Strategic Investment and Asian Production Hub Establishment: Significant investment of a total of $600 million in large-scale production and R&D facilities in Songdo, Incheon, for domestic production of key raw and auxiliary materials such as cell culture media, single-use bags, and filters, stabilizing the supply chain in Asia, and strengthening its role as a global export base.Strategic Investment and Asian Production Hub Establishment: Significant investment of a total of $600 million in large-scale production and R&D facilities in Songdo, Incheon, for domestic production of key raw and auxiliary materials such as cell culture media, single-use bags, and filters, stabilizing the supply chain in Asia, and strengthening its role as a global export base.
- Customized Services and Talent Development Support: Provision of process development and validation services, along with customized education and consulting services. Operation of the 'Sartorius Training Center,' a 2167m² dedicated educational facility for biopharmaceuticals, supporting practical capabilities for universities and public institutions and contributing to the development of domestic bio-talent.Customized Services and Talent Development Support: Provision of process development and validation services, along with customized education and consulting services. Operation of the 'Sartorius Training Center,' a 2167m² dedicated educational facility for biopharmaceuticals, supporting practical capabilities for universities and public institutions and contributing to the development of domestic bio-talent.
- Possession of Innovative High-Value Technologies: Core competencies in high-value technologies such as Disposable Technology and sensor technology, also providing solutions in specialized facility design fields like cGMP plant design and BSL-3,4, and animal facilities.Possession of Innovative High-Value Technologies: Core competencies in high-value technologies such as Disposable Technology and sensor technology, also providing solutions in specialized facility design fields like cGMP plant design and BSL-3,4, and animal facilities.
- Target Industrie
- Bio/Pharmaceutical Industry (development and production of therapeutic antibodies, biosimilars, vaccines, cell and gene therapies)Bio/Pharmaceutical Industry (development and production of therapeutic antibodies, biosimilars, vaccines, cell and gene therapies)
- Food Industry (R&D, quality assurance, manufacturing)Food Industry (R&D, quality assurance, manufacturing)
- Chemical Industry (R&D, quality assurance, manufacturing)Chemical Industry (R&D, quality assurance, manufacturing)
- Semiconductor Industry (R&D, quality assurance, manufacturing)Semiconductor Industry (R&D, quality assurance, manufacturing)
- Power Plants (R&D, quality assurance, manufacturing)Power Plants (R&D, quality assurance, manufacturing)
- Universities and Government Agencies (life science research and quality control)Universities and Government Agencies (life science research and quality control)
- Major Markets
- South Korea (production hub), Southeast Asia, Japan, Asian markets excluding ChinaSouth Korea (production hub), Southeast Asia, Japan, Asian markets excluding China
- EuropeEurope
- United StatesUnited States
- Certifications/Patents
- First domestic GMP certification for biopharmaceutical raw material manufacturing facilities (Ministry of Food and Drug Safety)First domestic GMP certification for biopharmaceutical raw material manufacturing facilities (Ministry of Food and Drug Safety)
- ISO 9001:2008, ISO/IEC 17502 certifications.ISO 9001:2008, ISO/IEC 17502 certifications.
- International Calibration Laboratory Accreditation (Korea Laboratory Accreditation Scheme, 2015)International Calibration Laboratory Accreditation (Korea Laboratory Accreditation Scheme, 2015)
- Grand Prize in Technology Sector at Excellent Company Awards (2015)Grand Prize in Technology Sector at Excellent Company Awards (2015)
- Recipient of 'Excellent Technology Grand Prize' at Korea Excellent Company Awards for 4 consecutive years (2021)Recipient of 'Excellent Technology Grand Prize' at Korea Excellent Company Awards for 4 consecutive years (2021)
- Recipient of the Korean Red Cross Humanitarian Service Award, Grand Honor Medal (2025)Recipient of the Korean Red Cross Humanitarian Service Award, Grand Honor Medal (2025)
- Prime Minister's Commendation for National Education Development (2021)Prime Minister's Commendation for National Education Development (2021)
- Million Dollar Export Tower Award (Korea International Trade Association, 2014)Million Dollar Export Tower Award (Korea International Trade Association, 2014)
- Sangheo Award in Academic and Education Sector (CEO Kim Deok-sang, 2024)Sangheo Award in Academic and Education Sector (CEO Kim Deok-sang, 2024)
- High-value technology capabilities including next-generation core technologies like Disposable Technology and sensor technology.High-value technology capabilities including next-generation core technologies like Disposable Technology and sensor technology.
Introduction
Location
220 Pangyoyeok-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
